Schedule 13G ownership disclosure

GALENA BIOPHARMA INC

Security class unavailable · CUSIP: 363256504

Event date: 2017-02-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,689,965
Percent of class
4.7200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-17-000071
Form type
SC 13G
Filer
SELLAS Life Sciences Group, Inc.
CIK
CIK 1390478
Filed
Feb 15, 2017
Reporting period
Feb 08, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub